GlabrolideCAS# 10401-33-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 10401-33-9 | SDF | Download SDF |
PubChem ID | 90479675 | Appearance | Powder |
Formula | C30H44O4 | M.Wt | 468.67 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2R,5S,6R,9R,11S,14S,15R,19S,21R)-11-hydroxy-2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.02,19.05,18.06,15.09,14]tetracos-17-ene-16,22-dione | ||
SMILES | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C | ||
Standard InChIKey | SSHDNSCEQSPWIM-FVTWEACWSA-N | ||
Standard InChI | InChI=1S/C30H44O4/c1-25(2)20-8-11-30(7)23(28(20,5)10-9-21(25)32)19(31)14-17-18-15-26(3)16-22(34-24(26)33)27(18,4)12-13-29(17,30)6/h14,18,20-23,32H,8-13,15-16H2,1-7H3/t18-,20-,21-,22+,23+,26+,27+,28-,29+,30+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
In vitro | Glycyrrhiza glabra linn commonly known as licorice: A therapeutic review.[Reference: WebLink]International Journal of Pharmacy & Pharmaceutical Sciences, 2011, 3(4):20-25.Plants have been one of the important sources of medicines since the beginning of human cultivation.
|
Glabrolide Dilution Calculator
Glabrolide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1337 mL | 10.6685 mL | 21.337 mL | 42.6739 mL | 53.3424 mL |
5 mM | 0.4267 mL | 2.1337 mL | 4.2674 mL | 8.5348 mL | 10.6685 mL |
10 mM | 0.2134 mL | 1.0668 mL | 2.1337 mL | 4.2674 mL | 5.3342 mL |
50 mM | 0.0427 mL | 0.2134 mL | 0.4267 mL | 0.8535 mL | 1.0668 mL |
100 mM | 0.0213 mL | 0.1067 mL | 0.2134 mL | 0.4267 mL | 0.5334 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Anemarrhenasaponin I
Catalog No.:BCN8559
CAS No.:163047-21-0
- Dihydropalmatine
Catalog No.:BCN8558
CAS No.:26067-60-7
- Rupestonic acid
Catalog No.:BCN8557
CAS No.:115473-63-7
- Uvarigranol B
Catalog No.:BCN8556
CAS No.:164204-79-9
- Ginsenoside Ra2
Catalog No.:BCN8555
CAS No.:83459-42-1
- Panasenoside
Catalog No.:BCN8554
CAS No.:31512-06-8
- Trans sodium crocetinate
Catalog No.:BCN8553
CAS No.:591230-99-8
- Ilexsaponin B2
Catalog No.:BCN8552
CAS No.:108906-69-0
- 28-Demethyl-beta-amyrone
Catalog No.:BCN8551
CAS No.:73493-60-4
- Vinaginsenoside R3
Catalog No.:BCN8550
CAS No.:156012-92-9
- Cistanoside F
Catalog No.:BCN8549
CAS No.:97411-47-7
- Rhein-8-glucoside
Catalog No.:BCN8548
CAS No.:34298-86-7
- Acanthopanaxoside B
Catalog No.:BCN8561
CAS No.:915792-03-9
- Erigoster B
Catalog No.:BCN8562
CAS No.:849777-61-3
- 3'-Demethylnobiletin
Catalog No.:BCN8563
CAS No.:112448-39-2
- Lancifodilactone F
Catalog No.:BCN8564
CAS No.:850878-47-6
- Periplocoside N
Catalog No.:BCN8565
CAS No.:39946-41-3
- 3-Feruloyl-1-Sinapoyl sucrose
Catalog No.:BCN8566
CAS No.:98942-06-4
- Vinaginsenoside R8
Catalog No.:BCN8567
CAS No.:156042-22-7
- Saikogenin D
Catalog No.:BCN8568
CAS No.:5573-16-0
- Gancaonin N
Catalog No.:BCN8569
CAS No.:129145-52-4
- Graveobioside A
Catalog No.:BCN8570
CAS No.:506410-53-3
- 2-Amino-3-carboxy-1,4-naphthoquinone
Catalog No.:BCN8571
CAS No.:173043-38-4
- 4'-O-Methylochnaflavone
Catalog No.:BCN8572
CAS No.:49619-87-6
In silico Inhibition of BACE-1 by Selective Phytochemicals as Novel Potential Inhibitors: Molecular Docking and DFT Studies.[Pubmed:30767744]
Curr Drug Discov Technol. 2019 Feb 14. pii: CDDT-EPUB-96664.
BACKGROUND: Alzheimer's disease (AD) has become the most common age-dependent disease of dementia. The trademark pathologies of AD are the presence of amyloid aggregates in neurofibrils. Recently phytochemicals being considered as potential inhibitors against various neurodegenerative, anti-fungal, antibacterial and antiviral diseases in human beings. OBJECTIVE: This study targets the inhibition of BACE-1 by phytochemicals using in silico drug discovery analysis. METHODS: A total of 3150 phytochemicals were collected from almost 25 different plants through literature assessment. The ADMET studies, molecular docking and density functional theory (DFT) based analysis was performed to analyze the potential inhibitory properties of these phytochemicals. RESULTS: The ADMET and docking results exposed seven compounds that have high potential as an inhibitory agent against BACE-1 and show binding affinity >8.0 kcal/mol against BACE-1. They show binding affinity greater than those of various previously reported inhibitors of BACE-1. Furthermore, DFT based analysis shown high reactivity for these seven phytochemicals in the binding pocket of BACE-1, based on ELUMO, EHOMO and Kohn-Sham energy gap. Seven out of seven phytochemicals are testified (as compared to experimental ones) as novel inhibitors against BACE-1. CONCLUSION: Out of seven phytochemicals, four are from plant Glycyrrhiza glabra i.e. Shinflavanone, Glabrolide, Glabrol and PrenyllicoflavoneA, one from Huperzia serrate i.e. Macleanine, one from Uncaria rhynchophylla i.e. 3a-dihydro-cadambine and another one is VolvalerelactoneB from plant Valeriana-officinalis. It is concluded that these phytochemicals are candidate for drug/inhibitor against BACE-1, and can be administered to humans after experimental validation through in vitro and in vivo trials.
Saponin and sapogenol. XLVIII. On the constituents of the roots of Glycyrrhiza uralensis Fischer from northeastern China. (2). Licorice-saponins D3, E2, F3, G2, H2, J2, and K2.[Pubmed:8403082]
Chem Pharm Bull (Tokyo). 1993 Aug;41(8):1337-45.
Following the characterization of licorice-saponins A3 (2), B2 (3), and C2 (4), the chemical structures of licorice-saponins D3 (5), E2 (6), F3 (7), G2 (8), H2 (9), J2 (10), and K2 (11), seven of the ten oleanane-type triterpene oligoglycosides isolated from the air-dried roots of Glycyrrhiza uralensis Fischer collected in the northeastern part of China, were investigated. On the basis of chemical and physicochemical evidence, the structures of licorice-saponins D3, E2, F3, G2, H2, J2, and K2 have been determined to be expressed as 3 beta-[alpha-L-rhamnopyranosyl(1-->2)-beta-D-glucuronopyranosyl(1-- >2)-beta-D-glucuronopyranosyloxy]-22 beta-acetoxyolean-12-en-30-oic acid (5), 3-O-[beta-D-glucuronopyranosyl(1-->2)-beta-D- glucuronopyranosyl]Glabrolide (6), 3-O-[alpha-L-rhamnopyranosyl(1-->2)-beta-D-glucuronopyranosyl(1--> 2)-beta-D-glucuronopyranosyl]-11-deoxoGlabrolide (7), 24-hydroxyglycyrrhizin (8), 3-O-[beta-D-glucuronopyranosyl(1-->2)-beta- D-glucuronopyranosyl]liquiritic acid (9), 24-hydroxy-11-deoxoglycyrrhizin (10), and 3 beta-[beta-D- glucuronopyranosyl(1-->2)-beta-D-glucuronopyranosyloxy]-24-+ ++hydroxyoleana- 11,13(18)-dien-30-oic acid (11), respectively.